NCT05416151View on ClinicalTrials.gov

Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms

NACompletedINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

April 18, 2024

Conditions
Gastro-intestinal Symptoms in Healthy Subjects
Interventions
OTHER

Freeze-dried biotic

2 sticks of 3g consumed daily for 28 days

OTHER

Maltodextrin

2 sticks of 3g consumed daily for 28 days

Trial Locations (1)

21000

CEN Experimental, Dijon

Sponsors

Collaborators (1)

Euraxi Pharma
All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

Danone Global Research & Innovation Center

INDUSTRY

NCT05416151 - Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms | Biotech Hunter | Biotech Hunter